Should You Buy, Hold or Sell TEM Stock Post Q3 Earnings Release?
Tempus AI posts first positive adjusted EBITDA and 84.7% revenue surge, signaling new growth momentum amid premium valuation.
10x Genomics ( TXG ) Reports Q3 Loss, Beats Revenue Estimates
10x Genomics (TXG) delivered earnings and revenue surprises of +18.52% and +4.64%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
10x Genomics ( TXG ) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
10x Genomics (TXG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Sustained Product Demand Drive HIMS Stock Before Q3 Earnings?
Hims & Hers benefits from strong platform engagement and hormonal health launches ahead of third-quarter 2025 earnings.
Cathie Wood Just Dumped More Palantir Shares Despite 'Holy Grail' AI Deal - Here's What Ark Bought Instead - Palantir Technologies ( NASDAQ:PLTR )
Cathie Wood-led Ark Invest made significant trades on Tuesday, focusing on companies like DraftKings Inc. ( NASDAQ:DKNG ) , Palantir Technologies Inc. ( NASDAQ:PLTR ) , and Shopify Inc. ( NASDAQ:SHOP ) .
Lancaster Opens $7 Million Position in 10x Genomics ( TXG )
On October 8, 2025, Lancaster Investment Management disclosed a new position in 10x Genomics ( NASDAQ:TXG ) . It opened its position in the single cell research company with the acquisition of around $7.27 million in shares.According to a filing with the Securities and Exchange Commission dated ...
10x Genomics ( TXG ) Moves 11.1% Higher: Will This Strength Last?
10x Genomics (TXG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations
PACB unveils new SPRQ-Nx chemistry to cut sequencing costs and boost multiomic features on Revio and Vega.
Tempus AI Stock Before Q3 Earnings Release: To Buy or Not to Buy?
TEM's 48% surge, key FDA clearances and bold AI acquisitions set the stage for its Q3 earnings reveal.
5 Must-Buy Efficient Stocks to Increase Your Portfolio Returns
From Red Robin to Analog Devices, these five high-efficiency stocks stand out for their strong ratios and surprise earnings potential.
10x Genomics ( TXG ) Upgraded to Strong Buy: Here's What You Should Know
10x Genomics (TXG) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns - Apple ( NASDAQ:AAPL ) , Amazon.com ( NASDAQ:AMZN )
Ark Invest CEO Cathie Wood told investors the real AI revolution isn't in chatbots or self-driving cars, it's happening in hospitals and labs and Wall Street is largely overlooking it. Speaking at the All-In Summit 2025 in September, Wood highlighted healthcare as "the most profound application ...
This Eaton Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Celsius Holdings ( NASDAQ:CELH ) , Eaton Corp ( NYSE:ETN )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
TEM Q2 Revenues Soar Amid Coverage Issues: Time to Buy, Hold or Sell?
Tempus AI posts 89.6% Q2 revenue growth, raises 2025 sales outlook again, and sees positive adjusted EBITDA ahead. What is the investment outlook?
5 Must-Buy Efficient Stocks to Buy Amid Volatile Market Conditions
Tsakos Energy Navigation, 10x Genomics, Pan American Silver, Wolverine World Wide, and Interface top an efficiency-driven stock screen.
10x Genomics ( TXG ) Surpasses Q2 Earnings and Revenue Estimates
10x Genomics (TXG) delivered earnings and revenue surprises of +180.00% and +24.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
10x Genomics ( TXG ) Upgraded to Buy: Here's Why
10x Genomics (TXG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Tempus AI Stock Before Q2 Earnings Release: To Buy or Not to Buy?
TEM surged 34.5% in Q2 on AI-driven deals and product momentum, but valuation and profit concerns linger ahead of earnings.
3 Medical Info Systems Stocks to Buy Amid AI Boom and Tariff Risk
AI momentum and rising demand for digital care put Zacks Medical Info Systems industry stocks like VEEV, TXG and IMDX in focus despite new tariff headwinds.
Genomics Market to Hit US$66.8 Billion by 2029 with 9.4% CAGR | MarketsandMarkets™.
Delray Beach, FL, June 11, 2025 ( GLOBE NEWSWIRE ) -- The global genomics market, valued at US$42.4 billion in 2023, stood at US$42.6 billion in 2024 and is projected to advance at a resilient CAGR of 9.4% from 2024 to 2029, culminating in a forecasted valuation of US$66.8 billion by the end of ...
What's Driving the Market Sentiment Around 10x Genomics? - 10x Genomics ( NASDAQ:TXG )
10x Genomics's TXG short percent of float has fallen 6.23% since its last report. The company recently reported that it has 14.88 million shares sold short, which is 20.03% of all regular shares that are available for trading.
Cathie Wood Sells Tesla Stock As Chinese Rivals Gain Ground - Ark Dumps Palantir Amid Privacy Concerns - ARK Innovation ETF ( BATS:ARKK ) , Palantir Technologies ( NASDAQ:PLTR )
On Monday, Cathie Wood-led Ark Invest made significant trades, notably offloading shares of Tesla Inc. TSLA and Palantir Technologies Inc. PLTR. The Tesla Trade: Ark Invest sold 1,594 shares of the Elon Musk-led company.
Wall Street Analysts Think 10x Genomics ( TXG ) Could Surge 43.12%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 43.1% in 10x Genomics (TXG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Cathie Wood Reiterates 'Profound' AI Application In Healthcare As Researchers Discover 'Cancer Survival Outcomes' By Facial Photograph Analysis: Here Are The Stocks That Could Benefit - Invesco QQQ Trust, Series 1 ( NASDAQ:QQQ ) , Illumina ( NASDAQ:ILMN )
Cathie Wood, the founder, CEO, and CIO of Ark Invest, underscored the application of artificial intelligence in the healthcare sector by sharing new research by Mass General Brigham, citing the discovery of cancer survival using facial photograph analysis.
Why 10x Genomics Stock Was Sliding This Week
Gene sequencing technology company 10x Genomics ( NASDAQ: TXG ) hasn't been having it easy in the past few days on the stock market. A bearish analyst move dampened sentiment on the company, and according to data compiled by S&P Global Market Intelligence its price was down by more than 9% week ...
10x Genomics ( TXG ) Upgraded to Buy: Here's What You Should Know
10x Genomics (TXG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Wall Street Analysts Believe 10x Genomics ( TXG ) Could Rally 55.85%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 55.9% in 10x Genomics (TXG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Cathie Wood Says AI Innovation In Healthcare Will Be More 'Profound' Than Autonomous Taxi Networks, Humanoid Robots - Amgen ( NASDAQ:AMGN ) , Bristol-Myers Squibb ( NYSE:BMY )
The Founder, CEO, and CIO of Ark Invest, Cathie Wood, has highlighted the rising applications of artificial intelligence and how it is poised to impact not only autonomous taxi networks and humanoid robots but also the health care space.
10x Genomics CEO Calls NIH The 'Foundational Jewel' Of Biomedical Progress, Says 40% To 50% Of Revenue Supported By Academic And Government Research Funding - Pulls Full Year Revenue Guidance - 10x Genomics ( NASDAQ:TXG )
During its first-quarter earnings call on Thursday, 10x Genomics Inc. TXG withdrew its full-year guidance, opting instead to provide quarterly forecasts. What Happened: The company cited policy uncertainty stemming from recent U.S. government budget cuts for academic research as the reason for ...
10x Genomics ( TXG ) Reports Q1 Loss, Tops Revenue Estimates
10x Genomics (TXG) delivered earnings and revenue surprises of 20% and 16.24%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Cathie Wood Pours $9.8 Million In Robinhood Despite Crypto Revenue Slump, Keeps Dumping Palantir Ahead Of Earnings - Advanced Micro Devices ( NASDAQ:AMD ) , ARK Innovation ETF ( BATS:ARKK )
On Thursday, Cathie Wood-led Ark Invest made significant trades involving Robinhood Markets Inc. HOOD, Advanced Micro Devices Inc. AMD, and Palantir Technologies Inc. PLTR. The Robinhood Trade saw Ark Invest's ARK Innovation ETF ARKK fund acquire 210,714 shares of Robinhood Markets Inc.
10x Genomics ( TXG ) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
10x Genomics (TXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cathie Wood Sells Palantir Shares Worth $2.65 Million Ahead Of Earnings, Doubles Down On This Chip Giant - Advanced Micro Devices ( NASDAQ:AMD ) , ARK Innovation ETF ( BATS:ARKK )
On Wednesday, Cathie Wood-led Ark Invest executed significant trades involving Palantir Technologies Inc. PLTR, Advanced Micro Devices Inc. AMD, and Shopify Inc. SHOP. Ark Invest made a notable move by selling shares of Palantir Technologies Inc.
Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings?
TEM's Genomics unit is expected to report strong growth for the first quarter, banking on continued unit growth pick-up.
Cathie Wood Buys More NVIDIA And AMD Stock As Chinese Tech Giants Stockpile Chips Amid Looming US Export Curbs - Advanced Micro Devices ( NASDAQ:AMD ) , Adaptive Biotechnologies ( NASDAQ:ADPT )
On Wednesday, Cathie Wood-led Ark Invest increased its exposure to NVIDIA Corp NVDA and Advanced Micro Devices Inc AMD. These trades come amid ongoing challenges in the semiconductor industry, particularly with U.S. sanctions affecting chip sales to China.
Cathie Wood's Thursday Plays: Healthcare AI And Crypto - Ark Scoops Up Tempus AI and Coinbase Stock Amid Trump Tariff Crash - Coinbase Global ( NASDAQ:COIN ) , ARK Innovation ETF ( BATS:ARKK )
On Thursday, Cathie Wood-led Ark Invest made notable trades, prominently featuring Tempus AI Inc TEM and Coinbase Global Inc COIN. The trades came as Wall Street reversed Wednesday's rally with a sharp selloff, as cooling inflation and hopes for Fed cuts were overshadowed by economic uncertainty ...
Life Science Company 10x Genomics Struggles With Profitability, Analyst Says 2025 Guidance Bakes In NIH Funding Uncertainties - 10x Genomics ( NASDAQ:TXG )
10x Genomics posted a Q4 EPS loss of $ ( 0.40 ) , missing the $ ( 0.30 ) estimate. The company's 2025 sales guidance of $610M-$630M is below the $631.14M consensus. Get access to your new suite of high-powered trading tools, including real-time stock ratings, insider trades, and ...
MGM Resorts To Rally Around 75%? Here Are 10 Top Analyst Forecasts For Thursday - Mr. Cooper Gr ( NASDAQ:COOP ) , Dutch Bros ( NYSE:BROS )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Needham raised Reddit, Inc. RDDT price target from $190 to $220. Needham analyst Laura Martin maintained a ...
10x Genomics ( TXG ) Reports Q4 Loss, Tops Revenue Estimates
10x Genomics (TXG) delivered earnings and revenue surprises of -25% and 0.03%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Seeking Clues to 10x Genomics ( TXG ) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for 10x Genomics (TXG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday
On Friday, Cathie Wood's Ark Invest made significant trades involving a number of prominent companies such as Amazon.com Inc AMZN, Robinhood Markets Inc HOOD, Palantir Technologies Inc PLTR, and Roblox Corp RBLX, among others.
Cathie Wood Sells Palantir Shares As Rally Cools Down, Ark Invest Also Dumps Nearly $7 Million Worth Of Robinhood Stock - ARK Innovation ETF ( ARCA:ARKK )
On Wednesday, Cathie Wood-led Ark Invest made significant trades involving Palantir Technologies Inc. PLTR and Robinhood Markets Inc. HOOD. These trades occurred amid notable developments in both companies, drawing attention from investors and market analysts.
10x Genomics ( TXG ) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
10x Genomics (TXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cathie Wood-Led Ark Invest Dumps $7M Worth Of Palantir Stock Amid Searing Rally - ARK Innovation ETF ( ARCA:ARKK ) , Palantir Technologies ( NASDAQ:PLTR )
On Tuesday, Cathie Wood-led Ark Invest made notable trades, including the sale of shares in Palantir Technologies Inc PLTR. This move came as Palantir's stock surged following its impressive fourth-quarter results and optimistic future guidance.
Cathie Wood's Ark Invest Bets On Biotech With CRISPR Therapeutics Investment, Exits Roblox - Archer Aviation ( NYSE:ACHR ) , Accolade ( NASDAQ:ACCD )
On Friday, Cathie Wood-led Ark Invest made significant trades involving CRISPR Therapeutics AG CRSP, 10X Genomics Inc. TXG, Roblox Corp. RBLX, Archer Aviation Inc. ACHR, Nu Holdings Ltd. NU, Adyen NV ADYEY, Accolade Inc. ACCD, and AeroVironment Inc. AVAV.
Cathie Wood's Ark Invest Dumps Over $10 Million Worth Of Palantir Stock As AI Competition Heats Up - Archer Aviation ( NYSE:ACHR ) , ARK Innovation ETF ( ARCA:ARKK )
On Thursday, Cathie Wood-led Ark Invest made significant trades involving Palantir Technologies Inc. PLTR. Ark Invest's decision to sell Palantir Technologies Inc. PLTR shares on Thursday comes amid a backdrop of competitive pressures in the AI space.
Tempus AI Stock Before Q4 Earnings: To Buy or Not to Buy?
TEM's Genomics unit is expected to report strong growth for the fourth quarter, banking on continued unit growth pick-up.
Here's Why You Should Retain PacBio Stock in Your Portfolio for Now
PACB continues to deliver growth from its unique technologies amid business seasonality concerns.
RNA Transcriptome Profiling Tests Market Expands at 14.5% CAGR, Surpassing US$ 37 Billion by 2034 | Fact.MR Report
Rockville, MD, Jan. 20, 2025 ( GLOBE NEWSWIRE ) -- According to Fact.MR, a market research and competitive intelligence provider, the global RNA transcriptome profiling test market is estimated to reach a valuation of US$ 9,652.2 million in 2024 and is expected to grow at a CAGR of 14.5% during ...
Cathie Wood's Pre-Christmas Sale: Ark Invest Dumps Even More Tesla, Palantir Stock - ARK Innovation ETF ( ARCA:ARKK )
A day before Christmas, on Tuesday, Cathie Wood-led Ark Invest made significant adjustments to its portfolio, notably selling shares of Tesla Inc. TSLA, Palantir Technologies Inc. PLTR, and Block Inc. SQ. Notably, Ark has been shedding shares of both Palantir and Tesla this week.
